Sataranatarajan K: Difference between revisions
From Bioblast
No edit summary |
m (moved Sataranatarajan Kavithalakshmi to Sataranatarajan K over redirect) |
||
| (2 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{Person | {{Person | ||
|lastname=Sataranatarajan | |lastname=Sataranatarajan | ||
|firstname=Kavithalakshmi | |firstname=Kavithalakshmi | ||
|institution=Oklahoma Medical Research Foundation | |||
|address=825 N.E. 13th Street | |||
|area code=OK 73104 | |||
|city=Oklahoma City | |||
|state=Oklahoma (OK) | |||
|country=USA | |||
}} | }} | ||
{{Labelingperson}} | {{Labelingperson}} | ||
Latest revision as of 16:39, 18 August 2014
| Name | Sataranatarajan Kavithalakshmi, |
|---|---|
| Institution | Oklahoma Medical Research Foundation |
| Address | 825 N.E. 13th Street, OK 73104 |
| City | Oklahoma City |
| State/Province | Oklahoma (OK) |
| Country | USA |
| Weblink | |
| O2k-Network Lab | US OK Oklahoma City Van Remmen H |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Dominguez-Lopez 2023 Neuropharmacology | 2023 | Dominguez-Lopez S, Ahn B, Sataranatarajan K, Ranjit R, Premkumar P, Van Remmen H, Beckstead MJ (2023) Long-term methamphetamine self-administration increases mesolimbic mitochondrial oxygen consumption and decreases striatal glutathione. https://doi.org/10.1016/j.neuropharm.2023.109436 |
| Pharaoh 2020 Sci Rep | 2020 | Pharaoh G, Brown JL, Sataranatarajan K, Kneis P, Bian J, Ranjit R, Hadad N, Georgescu C, Rabinovitch P, Ran Q, Wren JD, Freeman W, Kinter M, Richardson A, Van Remmen H (2020) Targeting cPLA2 derived lipid hydroperoxides as a potential intervention for sarcopenia. Sci Rep 10:13968. |
